Test Code VITB2 Riboflavin (Vitamin B2), Plasma
Useful For
Evaluation of individuals who present the signs of ariboflavinosis
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Reporting Name
Riboflavin (Vitamin B2), PSpecimen Type
Plasma HeparinShipping Instructions
Ship specimen in amber vial to protect from light.
Specimen Required
Patient Preparation: Fasting-overnight (12-14 hours) (infants-collect specimen prior to next feeding)
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Acceptable: Light-green top (sodium or lithium heparin plasma gel)
Submission Container/Tube: Amber vial
Specimen Volume: 2 mL
Collection Instructions: Centrifuge within 2 hours of collection and aliquot plasma into amber vial.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Heparin | Refrigerated (preferred) | 28 days | LIGHT PROTECTED |
Frozen | 28 days | LIGHT PROTECTED | |
Ambient | 72 hours | LIGHT PROTECTED |
Reference Values
1-19 mcg/L
Interpretation
Low concentrations in the blood plasma are indicative of nutritional deficiency. Concentrations below 1 mcg/L are considered significantly diminished. Marginally low levels probably represent nutritional deficiency that should be corrected.
Clinical Reference
1. McCormick DB. Riboflavin. In: Shils ME, Shike M, Ross AC, et al. Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams and Wilkins; 2006:434-441
2. Hustad S, McKinley MC, McNulty H, et al. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem. 2002;48(9):1571-1577
3. Roberts NB. Taylor A. Sodi R. Vitamins and trace elements. In: Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018:639-718
4. Balasubramaniam S, Christodoulou J, Rahman S. Disorders of riboflavin metabolism. J Inherit Metab Dis. 2019;42(4):608–619. doi:10.1002/jimd.12058
5. Suwannasom S, Kao I, PruB A, Georgieva R, Baumler H. Riboflavin: the health benefits of a forgotten natural vitamin. Int J Mol Sci. 2020;21(3):950. doi:10.3390/ijms21030950
6. O'Callaghan B, Bosch AM, Houlden H. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis. 2019;42(4):598-607. doi:10.1002/jimd.12053
Day(s) Performed
Monday, Wednesday, Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
84252
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
VITB2 | Riboflavin (Vitamin B2), P | 2924-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
61637 | Riboflavin (Vitamin B2), P | 2924-9 |